Quick Takeaways
- Monograph Capital Holdings Advisors, LLC filed SCHEDULE 13D/A for UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN).
- Disclosed ownership: 1.8%.
- Date of event: 05 Jun 2025.
Quoteable Key Fact
"Monograph Capital Holdings Advisors, LLC disclosed 1.8% ownership in UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN) on 05 Jun 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Monograph Capital Partners I, L.P. | 1.8% | 838,615 | 0 | 838,615 | /s/ Michael LaGatta | Michael LaGatta / Partner and Authorized Signatory | 0001864082 |
| Monograph Capital Partners I GenPar, LP | 1.8% | 838,615 | 0 | 838,615 | /s/ Michael LaGatta | Michael LaGatta / Partner and Authorized Signatory | |
| Monograph Capital Holdings Advisors, LLC | 1.8% | 838,615 | 0 | 838,615 | /s/ Michael LaGatta | Michael LaGatta / Partner and Authorized Signatory | 0001988760 |
| Fred Cohen | 1.9% | 838,615 | 15,000 | 838,615 | /s/ Michael LaGatta | Michael LaGatta/ Attorney-in-fact (1) | 0001339358 |
| Charles Conn | 1.8% | 838,615 | 0 | 838,615 | /s/ Michael LaGatta | Michael LaGatta/ Attorney-in-fact (2) |